ID

44446

Beskrivning

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01792206

Länk

https://clinicaltrials.gov/show/NCT01792206

Nyckelord

Versioner (1)
  1. 2021-09-22 2021-09-22 -
Rättsinnehavare

Scott and White Hospital & Clinic Abbott

Uppladdad den

22 september 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Type 2 Diabetes NCT01792206

Engelsk

Eligibility Type 2 Diabetes NCT01792206

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with type 2 diabetes and ckd
Beskrivning

Type 2 diabetes and Chronic Kidney Diseases

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C1561643
2. age 18 - 70 years
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
3. stable anti-hypertensive and lipid lowering therapy for at least 2 months. all patients should be on an acei or arb unless contraindicated because of side effects (standard of care). no changes in lipid lowering therapy during the 3 months of this study. blood pressure doses may be changed but new therapy with ace inhibitors will not be allowed.
Beskrivning

Stable anti-hypertensive therapy | Stable lipid lowering therapy | ACEi | ARB

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0585941
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0585943
UMLS CUI [2,2]
C0205360
UMLS CUI [3]
C0003015
UMLS CUI [4]
C0521942
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. severe co morbid conditions - e.g. cancer, etc.
Beskrivning

Severe comorbidity

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
2. congestive heart failure.
Beskrivning

Congestive heart failure

Datatyp

boolean

Alias
UMLS CUI [1]
C0018802
3. inability to give informed consent or attend study related visits.
Beskrivning

Unable to give an informed consent | Unable to attend study related visits

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0008952
UMLS CUI [2,2]
C1299582
4. have a history of abnormally high vitamin d or calcium levels in the bloodstream.
Beskrivning

Medical history of an abnormally high vitamin d or calcium levels

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0919758
UMLS CUI [1,3]
C0438215
UMLS CUI [1,4]
C0442805
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0201925
UMLS CUI [2,3]
C0438215
UMLS CUI [2,4]
C0442805
5. unwilling or unable to complete screening or data collection procedures.
Beskrivning

Protocol compliance unable | Protocol compliance unwilling

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C0558080
6. have a known allergy to the study drug.
Beskrivning

A known allergy to the study drug

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
7. pregnant or breast feeding
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
8. plasma calcium >9 mg/dl
Beskrivning

Calcium measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0201925
9. patients should discontinue any calcium supplementation prior to entry into the study.
Beskrivning

Calcium supplementation

Datatyp

boolean

Alias
UMLS CUI [1]
C1096745
10. other vitamin d analogs (eg sensipar) and vitamin d preparations are contraindicated
Beskrivning

Vitamin D supplement therapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0420176
UMLS CUI [1,2]
C0205394
Tillbaka till toppen

Similar models

Eligibility Type 2 Diabetes NCT01792206

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes and Chronic Kidney Diseases
Item
1. patients with type 2 diabetes and ckd
boolean
C0011860 (UMLS CUI [1,1])
C1561643 (UMLS CUI [1,2])
Age
Item
2. age 18 - 70 years
boolean
C0001779 (UMLS CUI [1])
Stable anti-hypertensive therapy | Stable lipid lowering therapy | ACEi | ARB
Item
3. stable anti-hypertensive and lipid lowering therapy for at least 2 months. all patients should be on an acei or arb unless contraindicated because of side effects (standard of care). no changes in lipid lowering therapy during the 3 months of this study. blood pressure doses may be changed but new therapy with ace inhibitors will not be allowed.
boolean
C0585941 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0585943 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0003015 (UMLS CUI [3])
C0521942 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Severe comorbidity
Item
1. severe co morbid conditions - e.g. cancer, etc.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Congestive heart failure
Item
2. congestive heart failure.
boolean
C0018802 (UMLS CUI [1])
Unable to give an informed consent | Unable to attend study related visits
Item
3. inability to give informed consent or attend study related visits.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0008952 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Medical history of an abnormally high vitamin d or calcium levels
Item
4. have a history of abnormally high vitamin d or calcium levels in the bloodstream.
boolean
C0262926 (UMLS CUI [1,1])
C0919758 (UMLS CUI [1,2])
C0438215 (UMLS CUI [1,3])
C0442805 (UMLS CUI [1,4])
C0262926 (UMLS CUI [2,1])
C0201925 (UMLS CUI [2,2])
C0438215 (UMLS CUI [2,3])
C0442805 (UMLS CUI [2,4])
Protocol compliance unable | Protocol compliance unwilling
Item
5. unwilling or unable to complete screening or data collection procedures.
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
A known allergy to the study drug
Item
6. have a known allergy to the study drug.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
7. pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Calcium measurement
Item
8. plasma calcium >9 mg/dl
boolean
C0201925 (UMLS CUI [1])
Calcium supplementation
Item
9. patients should discontinue any calcium supplementation prior to entry into the study.
boolean
C1096745 (UMLS CUI [1])
Vitamin D supplement therapy
Item
10. other vitamin d analogs (eg sensipar) and vitamin d preparations are contraindicated
boolean
C0420176 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial